Mark A Edgar Selected Research

Mark A Edgar Research Topics

Disease

12	Neoplasms (Cancer) 04/2023 - 05/2004
6	Glioma (Gliomas) 04/2010 - 05/2004
2	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 11/2011
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 07/2009
2	Necrosis 09/2016 - 02/2003
2	Hemangiosarcoma (Angiosarcoma) 01/2015 - 07/2009
2	Germinoma 03/2008 - 08/2006
1	Microsatellite Instability 04/2023
1	Lymphadenopathy 04/2023
1	Adenocarcinoma 04/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Cushing Syndrome 05/2019
1	Carcinoid Tumor (Carcinoid) 05/2019
1	Chondrosarcoma 10/2017
1	Diffuse Intrinsic Pontine Glioma 06/2014
1	Neurofibrosarcoma (MPNST) 07/2009
1	Chordoma 02/2009
1	Pain (Aches) 02/2009
1	Neoplasm Metastasis (Metastasis) 09/2008
1	Ependymoma 05/2008
1	Carcinoma (Carcinomatosis) 05/2008
1	Typical Teratoid Rhabdoid Tumor 03/2008
1	Craniopharyngioma (Craniopharyngiomas) 03/2008
1	Central Nervous System Neoplasms 03/2008
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 03/2008
1	Paraganglioma (Paragangliomas) 11/2007
1	Back Pain (Backache) 11/2007
1	Radiculopathy (Radiculopathy, Cervical) 11/2007
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2006
1	Cognitive Dysfunction 12/2006
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 08/2006
1	Teratoma (Teratoid Tumor) 08/2006
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 08/2006
1	Precocious Puberty 01/2006
1	Hypopigmentation (Hypomelanosis) 01/2006
1	Alzheimer Disease (Alzheimer's Disease) 11/2002

Drug/Important Bio-Agent (IBA)

3	8H9 monoclonal antibodyIBA 06/2014 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 12/2006
2	ErbB Receptors (EGF Receptor)IBA 03/2024 - 01/2009
2	Phosphotransferases (Kinase)IBA 08/2022 - 07/2009
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2006
2	Monoclonal AntibodiesIBA 04/2010 - 12/2008
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2024
1	MethyltransferasesIBA 03/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024
1	Circulating Tumor DNAIBA 04/2023
1	pembrolizumabIBA 04/2023
1	Tyrosine Kinase InhibitorsIBA 08/2022
1	tyrosine receptor (receptor, tyrosine)IBA 08/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2019
1	ChromatinIBA 09/2016
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Actins (F Actin)IBA 12/2014
1	S100 Proteins (S 100 Protein)IBA 05/2013
1	Brachyury protein (Brachyury)IBA 05/2013
1	Formaldehyde (Formol)FDA Link 11/2011
1	ParaffinIBA 11/2011
1	AntigensIBA 11/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2010
1	Immunotoxins (Immunotoxin)IBA 04/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2009
1	Sorafenib (BAY 43-9006)FDA Link 07/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2009
1	Immunoglobulins (Immunoglobulin)IBA 12/2008
1	ChromograninsIBA 05/2008
1	Glial Fibrillary Acidic ProteinIBA 05/2008
1	SynaptophysinIBA 05/2008
1	Mucin-1 (CA 15-3 Antigen)IBA 05/2008
1	Indicators and Reagents (Reagents)IBA 03/2008
1	AntibodiesIBA 03/2008
1	beta CateninIBA 03/2008
1	Immunoglobulin G (IgG)IBA 12/2006
1	AutoantibodiesIBA 12/2006
1	LipopolysaccharidesIBA 12/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2006
1	Proteins (Proteins, Gene)FDA Link 10/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2006
1	Tumor Biomarkers (Tumor Markers)IBA 08/2006
1	Cyproterone AcetateIBA 01/2006
1	Carmustine (FIVB)FDA Link 05/2004
1	IL13-PE38IBA 05/2004
1	Cytotoxins (Cytolysins)IBA 05/2004
1	Amyloid beta-PeptidesIBA 11/2002

Therapy/Procedure

8	Therapeutics 04/2023 - 01/2006
3	Radiotherapy 01/2018 - 08/2006
2	Drug Therapy (Chemotherapy) 04/2023 - 09/2008
1	Neoadjuvant Therapy 04/2023
1	Kidney Transplantation 01/2021
1	Radioimmunotherapy 06/2014
1	Image-Guided Radiotherapy 02/2009
1	Kyphoplasty 02/2009
1	Decompression 11/2007
1	Craniotomy 06/2006
1	Cannula 02/2003